To the Editor: In his Commentary,1 Dr
Rennie asks, “Can manufacturers produce a worthwhile register?”
As a pharmaceutical company that has created a register to communicate the
results of clinical trials of our marketed products, GlaxoSmithKline (GSK)
would like to bring to your attention the actions we have taken to make our
register worthwhile to the medical profession and others with an interest
in clinical research.
Krall R, Rockhold F. Trial Registration: Ignored to Irresistible. JAMA. 2005;293(2):158. doi:10.1001/jama.293.2.158-b
Customize your JAMA Network experience by selecting one or more topics from the list below.